Objective: The present study tests the ability of both zinc oxide (ZnONPs) and silver (SNPs) nanoparticles to ameliorate the oxidative stress resulted from diabetes in diabetic rats was tested in the present study.
Methods: Fifty male albino rats are randomly used; ten of them are served as a control and forty rats injected with single dose (100 mg/kg) of streptozotocin intraperitoneal. They were subdivided into, diabetic + ZnONPs, diabetic + SNPs and diabetic + insulin. The activities and mRNA expression levels of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GRD) were determined in brain tissues. Malondialdehyde (MDA), total antioxidant capacity (TAC), zinc (Zn) and silver (Ag) concentrations were estimated in the brain tissues of all rats.
Results: A significant increase in the activities and mRNA expression levels of SOD, CAT, GPx and GRD was shown. MDA levels were significantly decreased where there is a significant increase in the Zn, Ag and TAC in brain of ZnONPs and SNPs treated rats when compared with diabetic or diabetic + insulin and their control.
Conclusion: ZnONPs and SNPs can be used to ameliorate the oxidative stress in brain resulted from diabetes mellitus.
Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.